Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids
Products Related to Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids(138)
- GC403795(S)-HEPE MaxSpec® StandardCAS: 92008-51-0Purity: >95.00%
5(S)-HEPE is produced by 5-lipoxygenase catalyzed oxidation of eicosapentaenoic acid (EPA).
- GC403815-OxoETE MaxSpec® StandardCAS: 106154-18-1Purity: >95.00%
5-OxoETE is a polyunsaturated keto acid formed by the oxidation of 5-HETE in human neutrophils by a specific dehydrogenase.
- GC40386(±)11(12)-EpETECAS: 504435-15-8Purity: >98.00%
Eicosapentaenoic acid is converted to epoxyeicosatetraenoic acids (EpETE) by several cytochrome P450 isoforms.
- GC40387(±)11-HEPECAS: 99217-78-4Purity: >98.00%
(±)11-HEPE is produced by non-enzymatic oxidation of eicosapentaenoic acid.
- GC40420(±)15-HEDECAS: 77159-57-0Purity: >98.00%
(±)15-HEDE is produced by non-enzymatic oxidation of 11,14-eicosadienoic acid.
- GC40421(±)8(9)-EE-14(Z)-EPurity: >95.00%
(±)14(15)-EE-8(Z)-E is a potent vasodilator in bovine coronary arteries.
- GC4042211(R)-HEDECAS: 330800-88-9Purity: >98.00%
11(R)-HEDE is produced from 11Z,14Z-eicosadienoic acid by COX in a lipoxygenase-type reaction.
- GC4042311(S)-HEDECAS: 330800-90-3Purity: >98.00%
11(S)-HEDE is isolated by the chromatographic resolution of (±)11-HEDE.
- GC4042414,15-EE-5(Z)-ECAS: 519038-92-7Purity: >98.00%
Epoxyeicosatrienoic acids (EETs), such as 11(12)-EET and 14(15)-EET, are cytochrome P450 metabolites of arachidonic acid that have been identified as endothelium-derived hyperpolarizing factors with vasodilator activity.
- GC4042514,15-EE-8(Z)-ECAS: 519038-93-8Purity: >98.00%
Epoxyeicosatrienoic acids (EETs), such as 11(12)-EET and 14(15)-EET, are cytochrome P450 metabolites of arachidonic acid that have been identified as endothelium-derived hyperpolarizing factors with vasodilator activity.
- GC4042615(R)-HEDECAS: 83603-31-0Purity: >98.00%
15(R)-HEDE is isolated by the chromatographic resolution of (±)15-HEDE.
- GC40428(±)11-HEDECAS: 5598-37-8Purity: >98.00%
(±)11-HEDE is produced by non-enzymatic oxidation of 11,14-eicosadienoic acid.
- GC40429(±)12-HETECAS: 71030-37-0Purity: >95.00%
(±)12-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid.
- GC40430(±)14(15)-EETCAS: 197508-62-6Purity: >98.00%
(±)14(15)-EET is biosynthesized in rat and rabbit liver microsomes by CYP450.
- GC40433(±)15-HETE MaxSpec® StandardCAS: 71030-36-9Purity: >95.00%
(±)15-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid.
- GC40436(±)18-HETECAS: 133268-58-3Purity: >97.00%
(±)18-HETE is the racemic version of a cytochrome P450 (CYP450) metabolite of arachidonic acid.
- GC40437(±)5(6)-DiHET lactoneCAS: 213126-92-2Purity: >98.00%
5,6-DiHET lactone is a lactonized form of 5,6-EET and 5,6-DiHET.
- GC40440(±)8(9)-EETPurity: >98.00%
(±)8(9)-EET is a fully racemic version of the R/S enantiomeric forms biosynthesized from arachidonic acid.
- GC40444(5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic AcidCAS: 339534-01-9Purity: >98.00%
(5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic acid is a stable isomer of 15(S)-HETE, a major arachidonic acid metabolite from the 15-lipoxygenase pathway.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC40378 | 5(S)-HEPE | 92008-51-0 | >98.00% | |
5(S)-HEPE is produced by 5-lipoxygenase catalyzed oxidation of eicosapentaenoic acid (EPA). | ||||
| GC40379 | 5(S)-HEPE MaxSpec® Standard | 92008-51-0 | >95.00% | |
5(S)-HEPE is produced by 5-lipoxygenase catalyzed oxidation of eicosapentaenoic acid (EPA). | ||||
| GC40380 | 5-OxoETE | 106154-18-1 | >95.00% | |
5-OxoETE is a polyunsaturated keto acid formed by the oxidation of 5-HETE in human neutrophils by a specific dehydrogenase. | ||||
| GC40381 | 5-OxoETE MaxSpec® Standard | 106154-18-1 | >95.00% | |
5-OxoETE is a polyunsaturated keto acid formed by the oxidation of 5-HETE in human neutrophils by a specific dehydrogenase. | ||||
| GC40382 | 8(S)-HEPE | 118492-81-2 | >98.00% | |
8(S)-HEPE is a monohydroxy fatty acid produced by lipoxygenase oxidation of EPA. | ||||
| GC40386 | (±)11(12)-EpETE | 504435-15-8 | >98.00% | |
Eicosapentaenoic acid is converted to epoxyeicosatetraenoic acids (EpETE) by several cytochrome P450 isoforms. | ||||
| GC40387 | (±)11-HEPE | 99217-78-4 | >98.00% | |
(±)11-HEPE is produced by non-enzymatic oxidation of eicosapentaenoic acid. | ||||
| GC40420 | (±)15-HEDE | 77159-57-0 | >98.00% | |
(±)15-HEDE is produced by non-enzymatic oxidation of 11,14-eicosadienoic acid. | ||||
| GC40421 | (±)8(9)-EE-14(Z)-E | - | >95.00% | |
(±)14(15)-EE-8(Z)-E is a potent vasodilator in bovine coronary arteries. | ||||
| GC40422 | 11(R)-HEDE | 330800-88-9 | >98.00% | |
11(R)-HEDE is produced from 11Z,14Z-eicosadienoic acid by COX in a lipoxygenase-type reaction. | ||||
| GC40423 | 11(S)-HEDE | 330800-90-3 | >98.00% | |
11(S)-HEDE is isolated by the chromatographic resolution of (±)11-HEDE. | ||||
| GC40424 | 14,15-EE-5(Z)-E | 519038-92-7 | >98.00% | |
Epoxyeicosatrienoic acids (EETs), such as 11(12)-EET and 14(15)-EET, are cytochrome P450 metabolites of arachidonic acid that have been identified as endothelium-derived hyperpolarizing factors with vasodilator activity. | ||||
| GC40425 | 14,15-EE-8(Z)-E | 519038-93-8 | >98.00% | |
Epoxyeicosatrienoic acids (EETs), such as 11(12)-EET and 14(15)-EET, are cytochrome P450 metabolites of arachidonic acid that have been identified as endothelium-derived hyperpolarizing factors with vasodilator activity. | ||||
| GC40426 | 15(R)-HEDE | 83603-31-0 | >98.00% | |
15(R)-HEDE is isolated by the chromatographic resolution of (±)15-HEDE. | ||||
| GC40428 | (±)11-HEDE | 5598-37-8 | >98.00% | |
(±)11-HEDE is produced by non-enzymatic oxidation of 11,14-eicosadienoic acid. | ||||
| GC40429 | (±)12-HETE | 71030-37-0 | >95.00% | |
(±)12-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. | ||||
| GC40430 | (±)14(15)-EET | 197508-62-6 | >98.00% | |
(±)14(15)-EET is biosynthesized in rat and rabbit liver microsomes by CYP450. | ||||
| GC40433 | (±)15-HETE MaxSpec® Standard | 71030-36-9 | >95.00% | |
(±)15-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. | ||||
| GC40436 | (±)18-HETE | 133268-58-3 | >97.00% | |
(±)18-HETE is the racemic version of a cytochrome P450 (CYP450) metabolite of arachidonic acid. | ||||
| GC40437 | (±)5(6)-DiHET lactone | 213126-92-2 | >98.00% | |
5,6-DiHET lactone is a lactonized form of 5,6-EET and 5,6-DiHET. | ||||
| GC40439 | (±)5-HETE | 73307-52-5; 71030-39-2 | >95.00% | |
(±)5-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. | ||||
| GC40440 | (±)8(9)-EET | - | >98.00% | |
(±)8(9)-EET is a fully racemic version of the R/S enantiomeric forms biosynthesized from arachidonic acid. | ||||
| GC40443 | (±)9-HETE | 79495-85-5 | >98.00% | |
(±)9-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. | ||||
| GC40444 | (5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic Acid | 339534-01-9 | >98.00% | |
(5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic acid is a stable isomer of 15(S)-HETE, a major arachidonic acid metabolite from the 15-lipoxygenase pathway. | ||||
